000 | 00920 a2200217 4500 | ||
---|---|---|---|
005 | 20250517120350.0 | ||
008 | ####s 0 0 eng d | ||
022 | _a1432-0851 | ||
024 | 7 |
_a10.1007/s00262-016-1903-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRichards, John O | |
245 | 0 | 0 |
_aErratum to: NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells. _h[electronic resource] |
260 |
_bCancer immunology, immunotherapy : CII _c11 2016 |
||
300 |
_a1337 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Published Erratum | ||
700 | 1 | _aAlbers, Alex J | |
700 | 1 | _aSmith, Thomas S | |
700 | 1 | _aTjoe, Judy A | |
773 | 0 |
_tCancer immunology, immunotherapy : CII _gvol. 65 _gno. 11 _gp. 1337 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00262-016-1903-9 _zAvailable from publisher's website |
999 |
_c26477563 _d26477563 |